Company targets US regulatory approval for ‘mi

Ossium Health CEO Kevin Caldwell on reengineerin

Epicore Biosystems CEO on harnessing thousands o

First patients dosed with novel NAD+ precursor d

New £4.

Celebrity-backed proactive health platform wants

CRISPR-modified human iPSC-microglia respond to

Coya’s biologic therapeutic aims to suppress c

Metabolic feature of mutant stem cells offers a

New initiative to drive advancements in longevit

New data from a 12-week trial indicate that trea

Seveno Capital makes first investment and launch

Elevate Chief Medical Officer Nitin Shori on why

New Manulife-WEF initiative aims to ‘move the

Company targets Phase 2 trial of MKK4 inhibitor

Aubrey de Grey and James Strole look ahead to RA

‘Social wellness’ provider to offer custom-f

Abu Dhabi biotech collaboration aims to fast-tra

How mapping the ‘effectome’ allows General P

New funding follows impressive vision restoratio

A year-long study in healthy adults suggests sex

Subsense CEO on hacking the brain, treating neur

Companies to combine MEG and EEG tech to bring c

Treatment provides continuous dopaminergic stimu

TMEM65 found to support calcium clearance in cel

Partnership focuses on platform that enables dru

New book explores how an overlooked saturated fa

Agenda explores diagnostics, age reversal and pr

I Peace offers individuals the opportunity to pr

Clinical trial met all key endpoints, demonstrat

Nicola Marino, Director of AEON Foundation, on t

Junevity founder explains how developments in si

Startup leverages cultivated muscle tissue gener

Company demonstrates treatment with intravenous

Professionals across insurance, pensions and res

Plasma biomarker measuring tau tangles aids diag

Company’s ‘precise and reversible’ RNA-edi

Company’s ‘precise and reversible’ RNA-edi

Rejuve Longevity users can monetize their health

Company to expand multi-ancestry biobank to supp

Survey of 82 clinics highlights technology uptak

Startup aims for clinical trial of lead candidat

Eighteen-month expedition sets out to examine lo

ThirdLaw Molecular is developing a new class of

Trial aims to demonstrate capacity to extend hea

Landmark conference concludes with call for unif

ARMMs technology expands scope of potential epig

Research highlights role of C15:0 in cellular re

Company says senolytic therapeutic delivers ‘r

Startup boasts pipeline of candidates targeting